ASX 200 up more 2% than on vaccine hopes

The ASX 200 (ASX: XJO) is currently up more than 2% as investors react to the vaccine news.

What has happened with a vaccine?

According to reporting by international media, US business Moderna has announced that a vaccine may be able to help people’s immune system fight COVID-19.

Apparently antibodies were found in the first eight people who took part in the safety trials. The people’s immunity response was similar to people with the actual coronavirus.

The vaccine trial was run by the US government’s National Institute of Allergy and Infectious Diseases. A large trial is expected to take place in July.

Baby Bunting (ASX: BBN) share price soars

The Baby Bunting share price is currently up 13.5% after the baby product retailer gave a business update.

The retailer announced its trading performance for the second half from 30 December 2019 to 17 May 2020.

Total sales growth has been 13.2% with comparable store sales growth of 8.1%. Online sales are 17.3% of total sales, representing growth of around 66% compared to the prior corresponding period.

Baby Bunting also released its numbers on a financial year to date (YTD) basis. Total sales growth is 10.3%, comparable store sales growth is 3.4% and online sales have been 14.3% of total sales which represents growth of around 34%.

James Hardie Industries (ASX: JHX) share price jumps

The James Hardie Industries share price is up almost 10% after releasing its preliminary full year result.

The building materials business said that net sales were up 4% to US$2.6 billion. Net profit was up 6% to US$241.5 million.

As a reminder, the company announced the suspension of dividends until further notice on 5 May 2020.

Disclosure: Jaz does not own shares of any of the shares mentioned at the time of writing.

From 200+ ETFs in Australia, our top investment analyst has just identified his #1 ETF for 2021 and beyond.

Low fees? Check.

Long-term growth potential? Check.

Regular cash returns? Check!

This ETF makes investing in ETFs "Super-Easy".

Simply click here or enter your email address below to access the full ETF report, ticker code, and step-by-step investment guide. Our expert's #1 ETF report is completely free.

No gimmicks, no payment, no credit card info. Just enter your email address below and we'll send you the report right away.

From 200+ ETFs in Australia, our top investment analyst has just identified his #1 ETF for 2021 and beyond.

Low fees? Check.

Long-term growth potential? Check.

Regular cash returns? Check!

This ETF makes investing in ETFs "Super-Easy".

Simply click here to access the full ETF report, ticker code, and step-by-step investment guide. Our expert's #1 ETF report is completely free.

No gimmicks, no payment, no credit card info. Just click the link below and enter your email address. We'll send you the report right away.

CLICK HERE TO GET THE REPORT

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Keep reading:

General Financial Advice warning
The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms & Conditions and Financial Services Guide before using this website.

© Rask Australia 2020

Join 20,000+ smart investors

Join the Rask Australia mailing and we’ll send you free investment reports, podcasts, expert insights, investing courses, ASX news and lots, lots more. All free. 

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian-owned.

feedback-icon

What can we do better? Please give us us some feedback :)

We care about your experience, please let us know if you have any suggestions to improve our site.